Search

Bethany Samuelson Bannow, M.D., MCR

Bethany Samuelson Bannow, M.D., MCR

May 09, 2024

Bethany Samuelson Bannow, M.D., and colleagues at the OHSU Center for Women’s Health are working to reduce gaps in women’s health research. (OHSU/Christine Torres Hicks)

Chris Woods, M.D.

Chris Woods, M.D.

May 09, 2024

Chris Woods, M.D., professor of medicine and global health at the Duke University School of Medicine. (Photo courtesy Duke University)

Chip Walter, M.D.

Chip Walter, M.D.

May 09, 2024

Emmanuel Benjamin "Chip" Walter, M.D., professor of pediatrics at Duke University School of Medicine and member of the Duke Human Vaccine Institute. (Photo courtesy Duke University)

GIST trial

GIST trial

May 09, 2024

Diana Dowd, center, talks with her friend, Lauri Roskamp, right, during an appointment at OHSU, Jan. 8, 2020. Dowd took part in a clinical trial treating a rare stomach cancer, GIST, which was recently approved by the FDA. The scans show a comparison of Dowd's stomach tumors after, left, and before her treatment. (OHSU/Kristyna Wentz-Graff) EDITOR'S NOTE: PERSONAL INFORMATION HAS BEEN REMOVED FROM THE XRAYS. NO OTHER CONTENT HAS BEEN MODIFIED.

GIST trial

GIST trial

May 09, 2024

Michael Heinrich, M.D., left, talks with Diana Dowd, center and her friend Lauri Roskamp, during an appointment at OHSU, Jan. 8, 2020. Dowd took part in a clinical trial treating a rare stomach cancer, GIST, which was recently approved by the FDA. (OHSU/Kristyna Wentz-Graff)

GIST trial

GIST trial

May 09, 2024

Diana Dowd, center, has an appointment with Michael Heinrich, M.D., at OHSU, Jan. 8, 2020. Dowd took part in a clinical trial for a drug treating a rare stomach cancer, GIST. The drug that recently approved by the FDA. (OHSU/Kristyna Wentz-Graff)

GIST trial

GIST trial

May 09, 2024
Diana Dowd, center, talks with medical staff during an appointment at OHSU, Jan. 8, 2020. Dowd took part in a clinical trial treating a rare stomach cancer, GIST, which was recently approved by the FDA. Along with Dowd is her friend, Lauri Roskamp, right. (OHSU/Kristyna Wentz-Graff)
GIST trial

GIST trial

May 09, 2024
Diana Dowd, left, talks with Michael Heinrich, M.D., during an appointment at OHSU, Jan. 8, 2020. Dowd took part in a clinical trial treating a rare stomach cancer, GIST, which was recently approved by the FDA. Along with Dowd is her friend, Lauri Roskamp, center. (OHSU/Kristyna Wentz-Graff)
GIST trial

GIST trial

May 09, 2024
Diana Dowd, center, has an appointment with Michael Heinrich, M.D., at OHSU, Jan. 8, 2020. Dowd took part in a clinical trial for a drug treating a rare stomach cancer, GIST. The drug that was recently approved by the FDA. (OHSU/Kristyna Wentz-Graff)
See More Stories